Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Medpace Holdings, Inc. (MEDP)
USD530.19
-8.04 (-1.49%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
5375 Medpace Way 45227
Cincinnati, OH, US
Cincinnati, OH, US
CEO
August James Troendle
Website
medpace.com
IPO
2016-08-11
CIK 1668397 ISIN US58506Q1094
Description
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD530.19
-8.04 (-1.49%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
377.8K
Beta
1.15
Float Shares
23.00M
Free Float %
80.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.23% | +0.80% | +6.80% | -1.03% | -24.53% | -20.39% | +51.61% | +115.80% | +165.32% | +1,508.89% | +1,508.89% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (19 ratings, all time)
Hold
Price Targets & DCF
Current price
530.19
Low
400.00
-24.6%
Consensus
498.86
-5.9%
Median
484.00
-8.7%
High
582.00
+9.8%
DCF (Unlevered)
431.93
-18.5%
DCF (Levered)
658.18
+24.1%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
31% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 8 | 0 |
| Sell | 0 | -1 |
| Strong Sell | 1 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 5 |
462.20
-12.8%
|
| Last Year | 17 |
530.82
+0.1%
|
| All Time | 26 |
489.42
-7.7%
|
Quality scores
Altman Z-Score
6.81
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
★ Strong MOAT
-
Revenue growth Medical - Diagnostics & Research: +7.9%+20.0% ★ Q1'26: +26.5% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+21.0% Q1'26: +16.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%+21.6% Q1'26: +20.5% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+21.4% ★ Q1'26: +20.0% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%+212.3% ★ Q1'26: +517.9% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%-7.8% ★ Q1'26: -7.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×0.44× ★ Q1'26: 0.25× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 9 EPS Ana. |
Dec 2027 9 Rev. Ana. 9 EPS Ana. |
Dec 2028 9 Rev. Ana. 9 EPS Ana. |
Dec 2029 4 Rev. Ana. 3 EPS Ana. |
Dec 2030 4 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
421.58M
est: 369.57M (+14.1%)
|
436.15M
est: 384.38M (+13.5%)
|
704.59M
est: 697.42M (+1.0%)
|
860.97M
est: 851.66M (+1.1%)
|
925.93M
est: 912.22M (+1.5%)
|
1.14B
est: 1.14B (0.0%)
|
1.46B
est: 1.45B (+0.6%)
|
1.89B
est: 2.03B (-7.1%)
|
2.11B
est: 2.11B (+0.1%)
|
2.53B
est: 2.51B (+0.8%)
|
2.77B
2.73B – 2.81B
+10.3% YoY
|
2.91B
2.71B – 3.17B
+4.9% YoY
|
3.16B
3.14B – 3.18B
+8.7% YoY
|
3.53B
3.31B – 3.74B
+11.6% YoY
|
3.73B
3.50B – 3.96B
+5.8% YoY
|
| EBITDA |
99.46M
est: 75.27M (+32.1%)
|
110.98M
est: 101.87M (+8.9%)
|
139.85M
est: 111.74M (+25.2%)
|
150.45M
est: 131.19M (+14.7%)
|
186.57M
est: 163.10M (+14.4%)
|
219.73M
est: 195.79M (+12.2%)
|
301.04M
est: 222.98M (+35.0%)
|
363.15M
est: 540.90M (-32.9%)
|
476.12M
est: 561.26M (-15.2%)
|
570.50M
est: 669.12M (-14.7%)
|
738.19M
727.61M – 748.77M
+10.3% YoY
|
774.55M
722.56M – 844.72M
+4.9% YoY
|
842.28M
836.38M – 848.18M
+8.7% YoY
|
939.69M
881.37M – 997.82M
+11.6% YoY
|
993.85M
932.17M – 1.06B
+5.8% YoY
|
| EBIT |
41.34M
est: 69.16M (-40.2%)
|
64.50M
est: 59.49M (+8.4%)
|
101.05M
est: 80.45M (+25.6%)
|
127.26M
est: 111.36M (+14.3%)
|
167.04M
est: 145.24M (+15.0%)
|
198.62M
est: 174.37M (+13.9%)
|
278.70M
est: 199.53M (+39.7%)
|
336.83M
est: 533.14M (-36.8%)
|
446.87M
est: 553.21M (-19.2%)
|
542.38M
est: 659.53M (-17.8%)
|
727.60M
717.17M – 738.03M
+10.3% YoY
|
763.44M
712.20M – 832.61M
+4.9% YoY
|
830.20M
824.38M – 836.01M
+8.7% YoY
|
926.21M
868.72M – 983.51M
+11.6% YoY
|
979.60M
918.79M – 1.04B
+5.8% YoY
|
| Net Income |
13.43M
est: 49.20M (-72.7%)
|
39.12M
est: 35.87M (+9.1%)
|
73.19M
est: 58.35M (+25.4%)
|
100.44M
est: 87.90M (+14.3%)
|
145.38M
est: 127.25M (+14.3%)
|
181.85M
est: 159.74M (+13.8%)
|
245.37M
est: 178.50M (+37.5%)
|
282.81M
est: 339.65M (-16.7%)
|
404.39M
est: 352.15M (+14.8%)
|
451.12M
est: 438.17M (+3.0%)
|
502.70M
494.46M – 510.94M
+14.7% YoY
|
533.47M
509.13M – 563.55M
+6.1% YoY
|
605.63M
564.91M – 723.40M
+13.5% YoY
|
691.76M
635.95M – 747.40M
+14.2% YoY
|
722.53M
664.23M – 780.63M
+4.4% YoY
|
| SGA |
61.51M
est: 33.66M (+82.7%)
|
63.36M
est: 101.08M (-37.3%)
|
75.68M
est: 89.72M (-15.6%)
|
95.25M
est: 105.37M (-9.6%)
|
92.16M
est: 82.50M (+11.7%)
|
108.42M
est: 95.30M (+13.8%)
|
131.40M
est: 101.99M (+28.8%)
|
161.35M
est: 176.20M (-8.4%)
|
180.18M
est: 182.83M (-1.4%)
|
197.56M
est: 217.97M (-9.4%)
|
240.47M
237.02M – 243.91M
+10.3% YoY
|
252.31M
235.38M – 275.17M
+4.9% YoY
|
274.37M
272.45M – 276.30M
+8.7% YoY
|
306.11M
287.11M – 325.04M
+11.6% YoY
|
323.75M
303.66M – 343.78M
+5.8% YoY
|
| EPS |
0.38
est: 1.54 (-75.3%)
|
1.00
est: 1.50 (-33.4%)
|
2.05
est: 2.56 (-19.8%)
|
2.79
est: 2.92 (-4.4%)
|
4.07
est: 3.74 (+8.7%)
|
5.06
est: 4.78 (+5.9%)
|
7.57
est: 6.97 (+8.6%)
|
9.20
est: 11.03 (-16.6%)
|
13.06
est: 11.94 (+9.4%)
|
15.64
est: 14.80 (+5.6%)
|
16.99
16.75 – 17.30
+14.7% YoY
|
18.37
17.24 – 19.09
+8.2% YoY
|
20.84
19.13 – 24.50
+13.4% YoY
|
23.43
21.54 – 25.31
+12.4% YoY
|
24.47
22.50 – 26.44
+4.4% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-24 | RBC Capital | Outperform | Outperform | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
811.26M
OE per share TTM
27.56
Owner's Yield
6.38%
Maintenance CapEx ratio
11.32%
Maint CapEx / Avg PPE
14.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
733
Total invested
11.51B
Insider transactions (90d)
10
Beneficial owners (>5%)
6
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | T. ROWE PRICE ASSOCIATES, INC. | 16.62M | 9.90% | 46.6K | 3.8K | 3.55M | 47.8K | IA | Pennsylvania | 2019-03-11 | ↗ |
| 2 | August J. Troendle | 7.06M | 22.50% | 806.6K | 5.89M | 806.6K | 5.89M | IN | — | 2022-09-13 | ↗ |
| 3 | Medpace Investors, LLC | 5.89M | 18.80% | — | 5.89M | — | 5.89M | OO | — | 2022-09-13 | ↗ |
| 4 | (1) BlackRock, Inc. | 3.76M | 10.50% | 3.68M | — | 3.76M | — | HC | Delaware | 2022-01-27 | ↗ |
| 5 | The Vanguard Group - 23-1945930 | 3.17M | 8.82% | — | 55.1K | 3.09M | 80.4K | IA | Pennsylvania For | 2022-02-10 | ↗ |
| 6 | Wasatch Advisors, Inc. 87-0319391 | 2.43M | 6.80% | 2.43M | — | 2.43M | — | IA | — | 2022-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
733
-58 vs prev Q
New positions
87
Closed positions
146
Increased
323
Reduced
295
Put/Call ratio
1.86
Calls held
23.8K
Puts held
44.2K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | BLACKROCK, INC. | 2.41M +55.5K (+2.4%) | 1.36B +143.1M (+11.8%) | 8.36% +0.371 pp | 0.02% +0.002 pp | USD339.02 +65.7% | 6 qtrs — |
| 2 | VANGUARD GROUP INC | 2.26M -21.1K (-0.9%) | 1.27B +96.6M (+8.2%) | 7.84% +0.099 pp | 0.02% +0.001 pp | USD73.21 +667.2% | 38 qtrs — |
| 3 | AQR CAPITAL MANAGEMENT LLC | 1.35M +324.3K (+31.6%) | 758.06M +239.9M (+46.3%) | 4.68% +1.202 pp | 0.40% +0.066 pp | USD428.57 +31.1% | 32 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 667.3K +24.6K (+3.8%) | 374.84M +44.4M (+13.4%) | 2.31% +0.134 pp | 0.02% +0.002 pp | USD183.28 +206.4% | 38 qtrs — |
| 5 | STATE STREET CORP | 664.9K -8.2K (-1.2%) | 373.44M +27.3M (+7.9%) | 2.31% +0.022 pp | 0.01% +0.001 pp | USD115.82 +384.9% | 38 qtrs — |
| 6 | WASATCH ADVISORS LP | 648.3K -277.7K (-30.0%) | 364.12M -112.0M (-23.5%) | 2.29% -0.849 pp | 2.16% -0.398 pp | USD136.07 +312.8% | 29 qtrs — |
| 7 | BAILLIE GIFFORD & CO | 547.1K -37.7K (-6.4%) | 307.27M +6.6M (+2.2%) | 1.88% -0.099 pp | 0.26% +0.033 pp | USD335.61 +67.4% | 7 qtrs — |
| 8 | D. E. SHAW & CO., INC. | 528.2K -71.9K (-12.0%) | 296.68M -11.9M (-3.9%) | 1.83% -0.204 pp | 0.16% -0.012 pp | USD396.14 +41.8% | 35 qtrs — |
| 9 | INVESCO LTD. | 482.6K -54.8K (-10.2%) | 271.07M -5.2M (-1.9%) | 1.67% -0.149 pp | 0.04% -0.002 pp | USD306.27 +83.4% | 38 qtrs — |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 465.9K -27.7K (-5.6%) | 261.68M +7.9M (+3.1%) | 1.62% -0.059 pp | 0.41% +0.071 pp | USD274.98 +104.3% | 34 qtrs — |
| 11 | MORGAN STANLEY | 416.7K -94.2K (-18.4%) | 234.03M -28.7M (-10.9%) | 1.44% -0.288 pp | 0.01% -0.002 pp | USD269.36 +108.5% | 38 qtrs — |
| 12 | MAWER INVESTMENT MANAGEMENT LTD. | 407.3K -239.5K (-37.0%) | 228.76M -103.8M (-31.2%) | 1.41% -0.781 pp | 1.28% -0.445 pp | USD306.05 +83.5% | 4 qtrs — |
| 13 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 375.0K +60.9K (+19.4%) | 210.64M +49.1M (+30.4%) | 1.30% +0.235 pp | 0.12% +0.022 pp | USD452.84 +24.0% | 26 qtrs — |
| 14 | DIMENSIONAL FUND ADVISORS LP | 359.4K -28.7K (-7.4%) | 201.84M +2.3M (+1.2%) | 1.27% -0.046 pp | 0.04% -0.001 pp | USD155.22 +261.8% | 32 qtrs — |
| 15 | GOLDMAN SACHS GROUP INC | 347.0K +166.7K (+92.4%) | 194.92M +102.2M (+110.2%) | 1.20% +0.584 pp | 0.02% +0.013 pp | USD467.94 +20.0% | 38 qtrs — |
| 16 | UBS GROUP AG | 328.9K +81.3K (+32.8%) | 184.71M +57.4M (+45.1%) | 1.14% +0.300 pp | 0.03% +0.010 pp | USD388.36 +44.6% | 38 qtrs — |
| 17 | BESSEMER GROUP INC | 317.0K -24.9K (-7.3%) | 178.07M +2.3M (+1.3%) | 1.09% -0.068 pp | 0.27% +0.005 pp | USD295.90 +89.8% | 18 qtrs — |
| 18 | FRANKLIN RESOURCES INC | 299.5K +183.6K (+158.6%) | 168.20M +108.6M (+182.4%) | 1.04% +0.645 pp | 0.04% +0.026 pp | USD482.56 +16.4% | 24 qtrs — |
| 19 | MADISON ASSET MANAGEMENT, LLC | 277.8K -14.9K (-5.1%) | 156.00M +5.5M (+3.7%) | 0.96% -0.036 pp | 1.79% +0.135 pp | USD314.21 +78.7% | 5 qtrs — |
| 20 | RIVERBRIDGE PARTNERS LLC | 273.0K -92.1K (-25.2%) | 153.31M -34.4M (-18.3%) | 0.94% -0.298 pp | 2.87% -0.293 pp | USD198.79 +182.5% | 20 qtrs — |
| 21 | GIVERNY CAPITAL INC. | 263.3K +1.5K (+0.6%) | 147.89M +13.3M (+9.9%) | 0.91% +0.025 pp | 4.93% +0.372 pp | USD322.68 +74.1% | 10 qtrs — |
| 22 | AMERICAN CAPITAL MANAGEMENT INC | 224.4K -24.4K (-9.8%) | 126.02M -1.9M (-1.5%) | 0.78% -0.066 pp | 5.56% +0.465 pp | USD126.09 +345.4% | 24 qtrs — |
| 23 | NORTHERN TRUST CORP | 218.9K -23.5K (-9.7%) | 122.95M -1.7M (-1.3%) | 0.76% -0.063 pp | 0.02% 0.000 pp | USD177.45 +216.5% | 38 qtrs — |
| 24 | BANK OF AMERICA CORP /DE/ | 210.7K -18.7K (-8.1%) | 118.34M +413.3K (+0.4%) | 0.73% -0.047 pp | 0.01% +0.001 pp | USD250.00 +124.7% | 37 qtrs — |
| 25 | CLEARBRIDGE INVESTMENTS, LLC | 205.2K -51.4K (-20.0%) | 115.24M -16.7M (-12.6%) | 0.71% -0.159 pp | 0.09% -0.007 pp | USD384.85 +45.9% | 9 qtrs — |
| 26 | FMR LLC | 203.7K +195.9K (+2,507.1%) | 114.42M +110.4M (+2,748.0%) | 0.71% +0.680 pp | 0.01% +0.006 pp | USD548.90 +2.3% | 30 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 189.8K +1.2K (+0.6%) | 106.59M +9.6M (+9.9%) | 0.66% +0.018 pp | 0.02% +0.001 pp | USD97.37 +476.8% | 38 qtrs — |
| 28 | NORGES BANK | 181.9K +181.9K (+100.0%) | 102.16M +102.2M (+100.0%) | 0.63% +0.631 pp | 0.01% +0.011 pp | USD561.65 +0.0% | 1 qtrs NEW |
| 29 | FINDLAY PARK PARTNERS LLP | 174.4K -127.9K (-42.3%) | 97.95M -57.5M (-37.0%) | 0.60% -0.421 pp | 1.25% -0.383 pp | USD402.57 +39.5% | 8 qtrs — |
| 30 | NATIXIS ADVISORS, L.P. | 163.4K +13.4K (+8.9%) | 91.75M +14.7M (+19.0%) | 0.57% +0.058 pp | 0.13% +0.018 pp | USD350.38 +60.3% | 6 qtrs — |
| 31 | BANK OF NEW YORK MELLON CORP | 159.5K -5.8K (-3.5%) | 89.57M +4.6M (+5.4%) | 0.55% -0.008 pp | 0.02% -0.001 pp | USD81.12 +592.4% | 38 qtrs — |
| 32 | GW&K INVESTMENT MANAGEMENT, LLC | 156.2K -42.1K (-21.2%) | 87.73M -14.2M (-13.9%) | 0.54% -0.131 pp | 0.76% -0.143 pp | USD236.13 +137.9% | 21 qtrs — |
| 33 | QUBE RESEARCH & TECHNOLOGIES LTD | 153.7K +78.9K (+105.5%) | 86.32M +47.9M (+124.5%) | 0.53% +0.279 pp | 0.09% +0.048 pp | USD532.55 +5.5% | 3 qtrs — |
| 34 | PACER ADVISORS, INC. | 153.7K +42.4K (+38.1%) | 86.30M +29.1M (+50.8%) | 0.53% +0.152 pp | 0.22% +0.076 pp | USD473.82 +18.5% | 22 qtrs — |
| 35 | BOSTON TRUST WALDEN CORP | 148.0K -3.2K (-2.1%) | 83.12M +5.4M (+6.9%) | 0.51% -0.003 pp | 0.63% +0.057 pp | USD152.30 +268.8% | 24 qtrs — |
| 36 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 142.4K +13.8K (+10.7%) | 79.95M +13.8M (+20.9%) | 0.49% +0.057 pp | 0.21% +0.001 pp | USD341.05 +64.7% | 19 qtrs — |
| 37 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 139.4K -51.6K (-27.0%) | 78.27M -19.9M (-20.3%) | 0.48% -0.165 pp | 0.28% -0.055 pp | USD296.44 +89.5% | 17 qtrs — |
| 38 | FISHER ASSET MANAGEMENT, LLC | 138.8K +1.1K (+0.8%) | 77.96M +7.1M (+10.1%) | 0.48% +0.014 pp | 0.03% +0.001 pp | USD206.22 +172.4% | 36 qtrs — |
| 39 | JPMORGAN CHASE & CO | 136.0K -41.9K (-23.5%) | 76.37M -15.1M (-16.5%) | 0.47% -0.135 pp | 0.00% -0.001 pp | USD254.21 +120.9% | 34 qtrs — |
| 40 | THRIVENT FINANCIAL FOR LUTHERANS | 125.3K +9.3K (+8.0%) | 70.35M +10.7M (+18.0%) | 0.43% +0.038 pp | 0.12% +0.008 pp | USD345.08 +62.8% | 33 qtrs — |
| 41 | AMERIPRISE FINANCIAL INC | 125.0K +7.1K (+6.0%) | 70.18M +9.5M (+15.7%) | 0.43% +0.034 pp | 0.02% +0.002 pp | USD298.53 +88.1% | 35 qtrs — |
| 42 | ENVESTNET ASSET MANAGEMENT INC | 124.9K +11.3K (+9.9%) | 70.17M +11.7M (+20.1%) | 0.43% +0.048 pp | 0.02% +0.004 pp | USD280.89 +100.0% | 29 qtrs — |
| 43 | ROYAL BANK OF CANADA | 120.0K -39.1K (-24.6%) | 67.38M -14.4M (-17.6%) | 0.42% -0.123 pp | 0.01% -0.002 pp | USD290.35 +93.4% | 38 qtrs — |
| 44 | STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 119.1K +391.0 (+0.3%) | 66.90M +5.9M (+9.6%) | 0.41% +0.008 pp | 0.87% +0.080 pp | USD317.17 +77.1% | 18 qtrs — |
| 45 | UBS ASSET MANAGEMENT AMERICAS INC | 117.3K +37.8K (+47.6%) | 65.86M +25.0M (+61.2%) | 0.41% +0.145 pp | 0.01% +0.005 pp | USD350.87 +60.1% | 30 qtrs — |
| 46 | PRICE T ROWE ASSOCIATES INC /MD/ | 116.6K +14.3K (+13.9%) | 65.48M +12.9M (+24.5%) | 0.40% +0.057 pp | 0.01% +0.001 pp | USD131.68 +326.5% | 30 qtrs — |
| 47 | JANUS HENDERSON GROUP PLC | 103.2K +10.0K (+10.7%) | 57.98M +10.0M (+20.9%) | 0.36% +0.042 pp | 0.03% +0.004 pp | USD369.57 +52.0% | 28 qtrs — |
| 48 | CITIGROUP INC | 95.6K -1.0K (-1.1%) | 53.71M +4.0M (+8.1%) | 0.33% +0.004 pp | 0.02% +0.002 pp | USD314.40 +78.6% | 38 qtrs — |
| 49 | IEQ CAPITAL, LLC | 95.3K +29.9K (+45.7%) | 53.51M +19.9M (+59.2%) | 0.34% +0.115 pp | 0.16% +0.058 pp | USD485.46 +15.7% | 6 qtrs — |
| 50 | SMITH GROUP ASSET MANAGEMENT, LLC | 94.8K +7.6K (+8.7%) | 53.23M +8.4M (+18.7%) | 0.33% +0.033 pp | 2.82% +0.247 pp | USD338.43 +66.0% | 9 qtrs — |
| 51 | LOS ANGELES CAPITAL MANAGEMENT LLC | 89.7K +9.4K (+11.7%) | 52.08M +10.8M (+26.1%) | 0.31% +0.039 pp | 0.18% +0.037 pp | USD505.99 +11.0% | 17 qtrs — |
| 52 | ANNEX ADVISORY SERVICES, LLC | 91.7K -10.0K (-9.8%) | 51.50M -783.0K (-1.5%) | 0.32% -0.029 pp | 0.98% -0.129 pp | USD327.34 +71.6% | 11 qtrs — |
| 53 | RAYMOND JAMES FINANCIAL INC | 89.3K -15.9K (-15.1%) | 50.23M -3.9M (-7.1%) | 0.31% -0.047 pp | 0.02% -0.002 pp | USD332.23 +69.1% | 5 qtrs — |
| 54 | SEI INVESTMENTS CO | 89.3K -3.6K (-3.9%) | 50.15M +2.4M (+5.0%) | 0.31% -0.006 pp | 0.05% -0.002 pp | USD230.77 +143.4% | 32 qtrs — |
| 55 | TUDOR INVESTMENT CORP ET AL | 89.2K +66.2K (+287.8%) | 50.12M +38.3M (+323.7%) | 0.31% +0.231 pp | 0.09% +0.072 pp | USD497.76 +12.8% | 3 qtrs — |
| 56 | NUVEEN, LLC | 86.8K +27.5K (+46.3%) | 48.75M +18.2M (+59.8%) | 0.30% +0.100 pp | 0.01% +0.005 pp | USD408.61 +37.5% | 4 qtrs — |
| 57 | CAPITAL IMPACT ADVISORS, LLC | 84.0K +57.0K (+211.0%) | 47.16M +33.3M (+239.8%) | 0.29% +0.200 pp | 3.69% +0.585 pp | USD495.28 +13.4% | 4 qtrs — |
| 58 | FUNDSMITH LLP | 82.6K -45.0K (-35.3%) | 46.37M -19.2M (-29.3%) | 0.29% -0.146 pp | 0.27% -0.060 pp | USD332.23 +69.1% | 5 qtrs — |
| 59 | CERITY PARTNERS LLC | 81.0K +23.5K (+41.0%) | 45.48M +15.9M (+54.0%) | 0.28% +0.086 pp | 0.07% +0.018 pp | USD470.38 +19.4% | 13 qtrs — |
| 60 | CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 80.2K +15.0K (+23.0%) | 45.05M +11.5M (+34.3%) | 0.28% +0.057 pp | 0.08% +0.016 pp | USD370.01 +51.8% | 6 qtrs — |
| 61 | MAN GROUP PLC | 79.1K -9.3K (-10.5%) | 44.44M -1.0M (-2.2%) | 0.27% -0.025 pp | 0.08% -0.004 pp | USD354.09 +58.6% | 32 qtrs — |
| 62 | FULLER & THALER ASSET MANAGEMENT, INC. | 76.9K +3.8K (+5.3%) | 43.18M +5.6M (+15.0%) | 0.26% +0.017 pp | 0.15% +0.018 pp | USD158.99 +253.3% | 30 qtrs — |
| 63 | ARGENT CAPITAL MANAGEMENT LLC | 76.3K -2.8K (-3.5%) | 42.88M +2.2M (+5.4%) | 0.26% -0.005 pp | 1.22% +0.106 pp | USD303.87 +84.8% | 24 qtrs — |
| 64 | SPYGLASS CAPITAL MANAGEMENT LLC | 69.2K -81.7K (-54.2%) | 38.85M -38.7M (-49.9%) | 0.24% -0.272 pp | 1.94% -2.193 pp | USD288.14 +94.9% | 12 qtrs — |
| 65 | FIRST TRUST ADVISORS LP | 67.7K +57.9K (+589.0%) | 38.02M +33.0M (+652.6%) | 0.23% +0.201 pp | 0.03% +0.024 pp | USD519.69 +8.1% | 33 qtrs — |
| 66 | MAIRS & POWER INC | 66.7K -2.9K (-4.2%) | 37.44M +1.7M (+4.7%) | 0.23% -0.005 pp | 0.36% +0.024 pp | USD258.20 +117.5% | 14 qtrs — |
| 67 | NORDEA INVESTMENT MANAGEMENT AB | 63.8K +1.2K (+1.9%) | 35.93M +4.4M (+14.1%) | 0.22% +0.007 pp | 0.03% +0.003 pp | USD139.91 +301.4% | 25 qtrs — |
| 68 | RETIREMENT SYSTEMS OF ALABAMA | 62.6K -125.0 (-0.2%) | 35.14M +2.9M (+9.0%) | 0.22% +0.003 pp | 0.11% +0.007 pp | USD169.24 +231.9% | 22 qtrs — |
| 69 | RICE HALL JAMES & ASSOCIATES, LLC | 62.5K -28.9K (-31.6%) | 35.11M -11.9M (-25.3%) | 0.22% -0.093 pp | 1.93% -0.630 pp | USD143.97 +290.1% | 21 qtrs — |
| 70 | RHUMBLINE ADVISERS | 62.0K -1.6K (-2.5%) | 34.81M +2.1M (+6.5%) | 0.21% -0.001 pp | 0.03% +0.002 pp | USD90.06 +523.6% | 37 qtrs — |
| 71 | CONGRESS ASSET MANAGEMENT CO /MA | 60.4K -4.3K (-6.7%) | 33.91M +647.7K (+1.9%) | 0.21% -0.010 pp | 0.24% +0.017 pp | USD226.43 +148.0% | 26 qtrs — |
| 72 | SG AMERICAS SECURITIES, LLC | 60.1K +54.0K (+881.1%) | 33.78M +30.6M (+971.7%) | 0.21% +0.186 pp | 0.04% +0.033 pp | USD554.05 +1.4% | 33 qtrs — |
| 73 | CITADEL ADVISORS LLC | 59.7K +36.8K (+160.7%) | 33.55M +21.8M (+184.8%) | 0.21% +0.129 pp | 0.01% +0.003 pp | USD466.61 +20.4% | 24 qtrs — |
| 74 | RUSSELL INVESTMENTS GROUP, LTD. | 59.6K -5.0K (-7.7%) | 33.49M +337.7K (+1.0%) | 0.21% -0.012 pp | 0.04% -0.001 pp | USD262.14 +114.3% | 37 qtrs — |
| 75 | TWO SIGMA INVESTMENTS, LP | 57.4K -28.0K (-32.8%) | 32.23M -11.7M (-26.6%) | 0.20% -0.091 pp | 0.05% -0.020 pp | USD301.91 +86.0% | 13 qtrs — |
| 76 | PANAGORA ASSET MANAGEMENT INC | 54.7K +54.7K (+100.0%) | 30.70M +30.7M (+100.0%) | 0.19% +0.190 pp | 0.11% +0.109 pp | USD561.65 +0.0% | 1 qtrs NEW |
| 77 | DF DENT & CO INC | 54.7K -9.5K (-14.8%) | 30.70M -2.3M (-6.9%) | 0.19% -0.028 pp | 0.44% +0.016 pp | USD278.42 +101.7% | 20 qtrs — |
| 78 | MILLENNIUM MANAGEMENT LLC | 52.0K -64.6K (-55.4%) | 29.20M -30.8M (-51.3%) | 0.18% -0.215 pp | 0.01% -0.013 pp | USD309.01 +81.8% | 38 qtrs — |
| 79 | TD ASSET MANAGEMENT INC | 51.5K -76.6K (-59.8%) | 28.95M -36.9M (-56.1%) | 0.18% -0.256 pp | 0.02% -0.030 pp | USD288.42 +94.7% | 20 qtrs — |
| 80 | VICTORY CAPITAL MANAGEMENT INC | 49.9K +19.3K (+63.3%) | 28.00M +12.3M (+78.3%) | 0.17% +0.069 pp | 0.02% +0.007 pp | USD402.50 +39.5% | 32 qtrs — |
| 81 | RANGER INVESTMENT MANAGEMENT, L.P. | 48.7K -158.0 (-0.3%) | 27.36M +2.2M (+8.9%) | 0.17% +0.003 pp | 1.88% +0.125 pp | USD80.43 +598.3% | 29 qtrs — |
| 82 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 48.1K +2.0K (+4.3%) | 27.03M +3.3M (+13.9%) | 0.17% +0.014 pp | 0.02% +0.001 pp | USD138.38 +305.9% | 32 qtrs — |
| 83 | WELLINGTON MANAGEMENT GROUP LLP | 47.8K +36.2K (+311.9%) | 26.85M +20.9M (+350.0%) | 0.17% +0.126 pp | 0.00% +0.004 pp | USD488.36 +15.0% | 13 qtrs — |
| 84 | PRINCIPAL FINANCIAL GROUP INC | 47.7K -1.4K (-2.9%) | 26.79M +1.5M (+6.0%) | 0.16% -0.002 pp | 0.01% +0.001 pp | USD96.20 +483.8% | 31 qtrs — |
| 85 | VULCAN VALUE PARTNERS, LLC | 47.3K -152.9K (-76.4%) | 26.58M -76.7M (-74.3%) | 0.16% -0.515 pp | 0.48% -1.392 pp | USD294.76 +90.5% | 19 qtrs — |
| 86 | MITSUBISHI UFJ TRUST & BANKING CORP | 46.1K -9.7K (-17.4%) | 25.91M -2.8M (-9.8%) | 0.16% -0.031 pp | 0.06% -0.002 pp | USD376.50 +49.2% | 7 qtrs — |
| 87 | CAPTRUST FINANCIAL ADVISORS | 45.4K +782.0 (+1.8%) | 25.47M +2.6M (+11.2%) | 0.16% +0.006 pp | 0.05% +0.002 pp | USD327.99 +71.2% | 23 qtrs — |
| 88 | MARSHALL WACE, LLP | 45.0K +38.4K (+581.9%) | 25.25M +21.9M (+644.9%) | 0.16% +0.134 pp | 0.02% +0.020 pp | USD550.76 +2.0% | 5 qtrs — |
| 89 | WELLS FARGO & COMPANY/MN | 44.8K +633.0 (+1.4%) | 25.14M +2.5M (+10.8%) | 0.16% +0.006 pp | 0.00% +0.000 pp | USD211.22 +165.9% | 38 qtrs — |
| 90 | SWISS NATIONAL BANK | 44.3K -3.1K (-6.5%) | 24.89M +521.1K (+2.1%) | 0.15% -0.007 pp | 0.01% +0.001 pp | USD95.66 +487.1% | 37 qtrs — |
| 91 | LEGAL & GENERAL GROUP PLC | 44.1K +2.1K (+4.9%) | 24.76M +3.2M (+14.6%) | 0.15% +0.010 pp | 0.01% +0.001 pp | USD178.31 +215.0% | 37 qtrs — |
| 92 | ABRDN PLC | 42.7K +94.0 (+0.2%) | 24.01M +2.1M (+9.5%) | 0.15% +0.003 pp | 0.04% +0.003 pp | USD380.43 +47.6% | 9 qtrs — |
| 93 | TWO SIGMA ADVISERS, LP | 41.0K -47.2K (-53.6%) | 23.01M -22.3M (-49.3%) | 0.14% -0.157 pp | 0.04% -0.046 pp | USD274.06 +104.9% | 34 qtrs — |
| 94 | STIFEL FINANCIAL CORP | 40.6K -2.1K (-4.9%) | 22.79M +842.0K (+3.8%) | 0.14% -0.004 pp | 0.02% +0.001 pp | USD329.24 +70.6% | 22 qtrs — |
| 95 | ALGERT GLOBAL LLC | 39.7K -2.1K (-5.1%) | 22.29M +792.0K (+3.7%) | 0.14% -0.004 pp | 0.35% -0.012 pp | USD269.74 +108.2% | 18 qtrs — |
| 96 | MCGUIRE INVESTMENT GROUP, LLC | 39.1K -2.8K (-6.8%) | 21.94M +397.4K (+1.8%) | 0.13% -0.008 pp | 2.35% -0.096 pp | USD110.63 +407.7% | 26 qtrs — |
| 97 | CANDRIAM S.C.A. | 39.0K +21.8K (+126.7%) | 21.92M +13.1M (+147.6%) | 0.14% +0.077 pp | 0.11% +0.063 pp | USD489.14 +14.8% | 14 qtrs — |
| 98 | — | 38.0K -7.0K (-15.6%) | 21.34M -1.8M (-7.8%) | 0.13% -0.022 pp | 0.38% -0.019 pp | USD313.86 +78.9% | 3 qtrs — |
| 99 | MARINER, LLC | 37.8K +22.9K (+154.6%) | 21.25M +13.6M (+178.5%) | 0.13% +0.081 pp | 0.03% +0.015 pp | USD509.12 +10.3% | 14 qtrs — |
| 100 | LPL FINANCIAL LLC | 36.8K +10.5K (+39.8%) | 20.69M +7.1M (+52.7%) | 0.13% +0.038 pp | 0.01% +0.002 pp | USD405.14 +38.6% | 24 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.89
Neutral
Ratio by volume
0.67
Neutral
Buys
8
Sells
9
Shares acquired
64.8K
Shares disposed
96.5K
Cash buys
—
Cash sales
1.00
Net activity
-31,707
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | Zander Dani S. | Director | A-Award | A | Stock Option (Right to Buy) | 1,110 | 415.27 | 460.9K | 1,110 | D | ↗ |
| 2026-05-15 | McCarthy Cornelius P. III | Director | A-Award | A | Stock Option (Right to Buy) | 1,110 | 415.27 | 460.9K | 1,110 | D | ↗ |
| 2026-05-15 | Kraft Robert O. | Director | A-Award | A | Stock Option (Right to Buy) | 1,110 | 415.27 | 460.9K | 1,110 | D | ↗ |
| 2026-05-15 | Gwadry-Sridhar Femida H. | Director | A-Award | A | Stock Option (Right to Buy) | 1,110 | 415.27 | 460.9K | 1,110 | D | ↗ |
| 2026-05-15 | DAVENPORT FRED B JR | Director | A-Award | A | Stock Option (Right to Buy) | 1,110 | 415.27 | 460.9K | 1,110 | D | ↗ |
| 2026-05-15 | Carley Brian T | Director | A-Award | A | Stock Option (Right to Buy) | 1,110 | 415.27 | 460.9K | 1,110 | D | ↗ |
| 2026-04-24 | Troendle August J. | Director / Officer / 10% Owner | A-Award | A | Restricted Stock Unit | 10,000 | 0.00 | — | 10,000 | D | ↗ |
| 2026-04-24 | EWALD STEPHEN P | Officer | A-Award | A | Restricted Stock Unit | 5,000 | 0.00 | — | 5,000 | D | ↗ |
| 2026-04-24 | Brady Kevin M. | Officer | A-Award | A | Restricted Stock Unit | 5,000 | 0.00 | — | 5,000 | D | ↗ |
| 2026-04-24 | BURWIG SUSAN E | Officer | A-Award | A | Restricted Stock Unit | 5,000 | 0.00 | — | 5,000 | D | ↗ |
| 2026-03-31 | McCarthy Cornelius P. III | Director | M-Exempt | D | Restricted Stock Unit | 29 | 0.00 | — | 84 | D | ↗ |
| 2026-03-31 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 33 | 0.00 | — | 922 | D | ↗ |
| 2026-03-31 | Carley Brian T | Director | M-Exempt | D | Restricted Stock Unit | 36 | 0.00 | — | 107 | D | ↗ |
| 2026-03-18 | BURWIG SUSAN E | Officer | M-Exempt | A | Common Stock | 12,000 | 166.73 | 2.00M | 70,484 | D | ↗ |
| 2026-03-17 | GEIGER JESSE J | Officer | M-Exempt | A | Common Stock | 31,707 | 138.87 | 4.40M | 46,707 | D | ↗ |
| 2026-02-17 | EWALD STEPHEN P | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 3,500 | 138.87 | 486.0K | 19,849 | D | ↗ |
| 2026-02-13 | Carley Brian T | Director | M-Exempt | D | Stock Option (Right to Buy) | 6,472 | 54.99 | 355.9K | 0 | D | ↗ |
| 2026-02-13 | BURWIG SUSAN E | Officer | M-Exempt | A | Common Stock | 10,984 | 107.93 | 1.19M | 58,484 | D | ↗ |
| 2025-12-31 | McCarthy Cornelius P. III | Director | M-Exempt | A | Common Stock | 49 | 0.00 | — | 10,295 | D | ↗ |
| 2025-12-31 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 56 | 0.00 | — | 889 | D | ↗ |
| 2025-12-31 | Carley Brian T | Director | M-Exempt | A | Common Stock | 62 | 0.00 | — | 26,281 | D | ↗ |
| 2025-12-05 | BURWIG SUSAN E | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 10,000 | 107.93 | 1.08M | 10,984 | D | ↗ |
| 2025-12-03 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 668 | 590.69 | 394.6K | 646,184 | D | ↗ |
| 2025-12-02 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,698 | 590.47 | 3.36M | 646,852 | D | ↗ |
| 2025-12-02 | BURWIG SUSAN E | Officer | M-Exempt | A | Common Stock | 10,000 | 107.93 | 1.08M | 37,500 | D | ↗ |
| 2025-12-01 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 23,178 | 593.25 | 13.75M | 652,550 | D | ↗ |
| 2025-11-28 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,151 | 593.46 | 8.99M | 675,728 | D | ↗ |
| 2025-11-28 | McCarthy Cornelius P. III | Director | A-Award | A | Restricted Stock Unit | 113 | 0.00 | — | 113 | D | ↗ |
| 2025-11-28 | Kraft Robert O. | Director | A-Award | A | Restricted Stock Unit | 130 | 0.00 | — | 130 | D | ↗ |
| 2025-11-28 | Carley Brian T | Director | A-Award | A | Restricted Stock Unit | 143 | 0.00 | — | 143 | D | ↗ |
| 2025-11-26 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 41,331 | 606.88 | 25.08M | 690,879 | D | ↗ |
| 2025-11-25 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 42,392 | 615.52 | 26.09M | 732,210 | D | ↗ |
| 2025-11-24 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 59,025 | 607.78 | 35.87M | 774,602 | D | ↗ |
| 2025-11-24 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 20,000 | 609.15 | 12.18M | 27,500 | D | ↗ |
| 2025-11-21 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 21,858 | 592.18 | 12.94M | 833,627 | D | ↗ |
| 2025-11-21 | Brady Kevin M. | Officer | M-Exempt | A | Common Stock | 3,000 | 166.73 | 500.2K | 9,000 | D | ↗ |
| 2025-11-20 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,830 | 598.49 | 4.09M | 855,485 | D | ↗ |
| 2025-11-19 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 23,862 | 592.07 | 14.13M | 862,315 | D | ↗ |
| 2025-11-18 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,191 | 590.84 | 4.25M | 886,177 | D | ↗ |
| 2025-11-17 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 6,047 | 591.00 | 3.57M | 893,368 | D | ↗ |
| 2025-11-14 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 14,747 | 595.26 | 8.78M | 899,415 | D | ↗ |
| 2025-11-14 | Kraft Robert O. | Director | M-Exempt | D | Stock Option (Right to Buy) | 6,472 | 54.99 | 355.9K | 0 | D | ↗ |
| 2025-11-13 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,128 | 601.37 | 3.08M | 914,162 | D | ↗ |
| 2025-11-12 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,312 | 603.23 | 3.20M | 919,290 | D | ↗ |
| 2025-11-11 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 18,000 | 605.00 | 10.89M | 47,500 | D | ↗ |
| 2025-11-05 | GEIGER JESSE J | Officer | S-Sale | D | Common Stock | 21,503 | 595.66 | 12.81M | 15,000 | D | ↗ |
| 2025-10-30 | DAVENPORT FRED B JR | Director | M-Exempt | A | Common Stock | 6,472 | 54.99 | 355.9K | 9,470 | D | ↗ |
| 2025-10-29 | GEIGER JESSE J | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 3,568 | 166.73 | 594.9K | 0 | D | ↗ |
| 2025-10-27 | GEIGER JESSE J | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 19,460 | 166.73 | 3.24M | 3,568 | D | ↗ |
| 2025-10-27 | EWALD STEPHEN P | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 18,230 | 166.73 | 3.04M | 0 | D | ↗ |
| 2025-10-27 | Brady Kevin M. | Officer | — | D | Employee Stock Option (Right to Buy) | 3,000 | 166.73 | 500.2K | 0 | — | ↗ |
| 2025-10-27 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 2,000 | 605.01 | 1.21M | 65,500 | D | ↗ |
| 2025-09-30 | McCarthy Cornelius P. III | Director | M-Exempt | A | Common Stock | 49 | 0.00 | — | 10,246 | D | ↗ |
| 2025-09-30 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 57 | 0.00 | — | 833 | D | ↗ |
| 2025-09-30 | Carley Brian T | Director | M-Exempt | D | Restricted Stock Unit | 62 | 0.00 | — | 62 | D | ↗ |
| 2025-09-26 | BURWIG SUSAN E | Officer | M-Exempt | A | Common Stock | 10,000 | 107.93 | 1.08M | 67,500 | D | ↗ |
| 2025-09-03 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 10,000 | 480.00 | 4.80M | 57,500 | D | ↗ |
| 2025-09-02 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,197 | 475.11 | 568.7K | 924,602 | D | ↗ |
| 2025-08-29 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 36,196 | 475.90 | 17.23M | 925,799 | D | ↗ |
| 2025-08-27 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 620 | 475.00 | 294.5K | 961,995 | D | ↗ |
| 2025-08-26 | BURWIG SUSAN E | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 10,000 | 107.93 | 1.08M | 40,984 | D | ↗ |
| 2025-08-19 | McCarthy Cornelius P. III | Director | S-Sale | D | Common Stock | 1,662 | 465.04 | 772.9K | 10,197 | D | ↗ |
| 2025-07-28 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 48,487 | 451.69 | 21.90M | 962,615 | D | ↗ |
| 2025-07-28 | EWALD STEPHEN P | Officer | S-Sale | D | Common Stock | 3,000 | 450.00 | 1.35M | 10,343 | D | ↗ |
| 2025-07-28 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 7,500 | 450.14 | 3.38M | 57,500 | D | ↗ |
| 2025-07-24 | GEIGER JESSE J | Officer | M-Exempt | A | Common Stock | 41,801 | 107.93 | 4.51M | 78,304 | D | ↗ |
| 2025-07-24 | Brady Kevin M. | Officer | M-Exempt | A | Common Stock | 12,000 | 57.94 | 695.3K | 18,000 | D | ↗ |
| 2025-07-22 | McCarthy Cornelius P. III | Director | M-Exempt | A | Common Stock | 1,972 | 54.99 | 108.4K | 11,859 | D | ↗ |
| 2025-06-30 | McCarthy Cornelius P. III | Director | M-Exempt | D | Restricted Stock Unit | 50 | 0.00 | — | 98 | D | ↗ |
| 2025-06-30 | Kraft Robert O. | Director | M-Exempt | D | Restricted Stock Unit | 57 | 0.00 | — | 113 | D | ↗ |
| 2025-06-30 | Carley Brian T | Director | M-Exempt | D | Restricted Stock Unit | 62 | 0.00 | — | 124 | D | ↗ |
| 2025-05-16 | Zander Dani S. | Director | A-Award | A | Stock Option (Right to Buy) | 1,224 | 305.66 | 374.1K | 1,224 | D | ↗ |
| 2025-05-16 | McCarthy Cornelius P. III | Director | A-Award | A | Stock Option (Right to Buy) | 1,224 | 305.66 | 374.1K | 1,224 | D | ↗ |
| 2025-05-16 | Kraft Robert O. | Director | A-Award | A | Stock Option (Right to Buy) | 1,224 | 305.66 | 374.1K | 1,224 | D | ↗ |
| 2025-05-16 | Gwadry-Sridhar Femida H. | Director | A-Award | A | Stock Option (Right to Buy) | 1,224 | 305.66 | 374.1K | 1,224 | D | ↗ |
| 2025-05-16 | DAVENPORT FRED B JR | Director | A-Award | A | Stock Option (Right to Buy) | 1,224 | 305.66 | 374.1K | 1,224 | D | ↗ |
| 2025-05-16 | Carley Brian T | Director | A-Award | A | Stock Option (Right to Buy) | 1,224 | 305.66 | 374.1K | 1,224 | D | ↗ |
| 2025-04-24 | DAVENPORT FRED B JR | Director | M-Exempt | A | Common Stock | 4,710 | 57.17 | 269.3K | 4,710 | D | ↗ |
| 2025-03-31 | McCarthy Cornelius P. III | Director | M-Exempt | D | Restricted Stock Unit | 50 | 0.00 | — | 148 | D | ↗ |
| 2025-03-31 | Kraft Robert O. | Director | M-Exempt | D | Restricted Stock Unit | 57 | 0.00 | — | 170 | D | ↗ |
| 2025-03-31 | Carley Brian T | Director | M-Exempt | D | Restricted Stock Unit | 63 | 0.00 | — | 186 | D | ↗ |
| 2025-03-07 | Troendle August J. | Director / Officer / 10% Owner | M-Exempt | A | Common Stock | 84,770 | 107.93 | 9.15M | 1,011,102 | D | ↗ |
| 2025-03-06 | Troendle August J. | Director / Officer / 10% Owner | A-Award | A | Employee Stock Option (Right to Buy) | 73,443 | 325.73 | 23.92M | 73,443 | D | ↗ |
| 2025-03-06 | GEIGER JESSE J | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 9,886 | 325.73 | 3.22M | 9,886 | D | ↗ |
| 2025-03-06 | EWALD STEPHEN P | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 6,591 | 325.73 | 2.15M | 6,591 | D | ↗ |
| 2025-03-06 | Brady Kevin M. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 6,591 | 325.73 | 2.15M | 6,591 | D | ↗ |
| 2025-03-06 | BURWIG SUSAN E | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 11,017 | 325.73 | 3.59M | 11,017 | D | ↗ |
| 2025-02-27 | EWALD STEPHEN P | Officer | P-Purchase | A | Common Stock | 2 | 326.11 | 652.22 | 13,343 | D | ↗ |
| 2025-02-24 | Carley Brian T | Director | S-Sale | D | Common Stock | 4,003 | 345.59 | 1.38M | 26,032 | D | ↗ |
| 2024-12-31 | McCarthy Cornelius P. III | Director | M-Exempt | D | Restricted Stock Unit | 62 | 0.00 | — | 0 | D | ↗ |
| 2024-12-31 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 71 | 0.00 | — | 662 | D | ↗ |
| 2024-12-31 | Carley Brian T | Director | M-Exempt | A | Common Stock | 78 | 0.00 | — | 21,908 | D | ↗ |
| 2024-12-06 | GEIGER JESSE J | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 15,000 | 32.05 | 480.8K | 0 | D | ↗ |
| 2024-11-29 | McCarthy Cornelius P. III | Director | A-Award | A | Restricted Stock Unit | 198 | 0.00 | — | 198 | D | ↗ |
| 2024-11-29 | Kraft Robert O. | Director | A-Award | A | Restricted Stock Unit | 227 | 0.00 | — | 227 | D | ↗ |
| 2024-11-29 | Carley Brian T | Director | A-Award | A | Restricted Stock Unit | 249 | 0.00 | — | 249 | D | ↗ |
| 2024-11-19 | BURWIG SUSAN E | Officer | M-Exempt | A | Common Stock | 7,500 | 32.05 | 240.4K | 65,000 | D | ↗ |
| 2024-09-30 | McCarthy Cornelius P. III | Director | M-Exempt | A | Common Stock | 62 | 0.00 | — | 5,225 | D | ↗ |
| 2024-09-30 | Kraft Robert O. | Director | M-Exempt | D | Restricted Stock Unit | 71 | 0.00 | — | 71 | D | ↗ |
| 2024-09-30 | Carley Brian T | Director | M-Exempt | D | Restricted Stock Unit | 78 | 0.00 | — | 78 | D | ↗ |
| 2024-08-23 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 3,774 | 42.62 | 160.8K | 4,294 | — | ↗ |
| 2024-08-22 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 4,353 | 42.62 | 185.5K | 4,873 | — | ↗ |
| 2024-08-05 | Troendle August J. | Director / Officer / 10% Owner | A-Award | A | Employee Stock Option (Right to Buy) | 50,000 | 377.00 | 18.85M | 50,000 | — | ↗ |
| 2024-08-05 | GEIGER JESSE J | Officer | A-Award | A | Restricted Stock Unit | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2024-08-05 | EWALD STEPHEN P | Officer | A-Award | A | Restricted Stock Unit | 7,500 | 0.00 | — | 7,500 | — | ↗ |
| 2024-08-05 | Brady Kevin M. | Officer | A-Award | A | Restricted Stock Unit | 7,500 | 0.00 | — | 7,500 | — | ↗ |
| 2024-08-05 | BURWIG SUSAN E | Officer | M-Exempt | A | Common Stock | 50,000 | 90.65 | 4.53M | 57,500 | — | ↗ |
| 2024-07-01 | Zander Dani S. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-30 | McCarthy Cornelius P. III | Director | M-Exempt | A | Common Stock | 62 | 0.00 | — | 5,163 | — | ↗ |
| 2024-06-30 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 72 | 0.00 | — | 520 | — | ↗ |
| 2024-06-30 | Carley Brian T | Director | M-Exempt | A | Common Stock | 78 | 0.00 | — | 21,752 | — | ↗ |
| 2024-06-05 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 7,681 | 401.20 | 3.08M | 7,500 | — | ↗ |
| 2024-05-28 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 5,695 | 395.49 | 2.25M | 654,656 | — | ↗ |
| 2024-05-24 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,987 | 395.22 | 1.58M | 660,351 | — | ↗ |
| 2024-05-22 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 55 | 400.00 | 22.0K | 664,338 | — | ↗ |
| 2024-05-20 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,020 | 400.19 | 1.61M | 664,393 | — | ↗ |
| 2024-05-17 | McCarthy Cornelius P. III | Director | A-Award | A | Stock Option (Right to Buy) | 953 | 393.30 | 374.8K | 953 | — | ↗ |
| 2024-05-17 | Kraft Robert O. | Director | A-Award | A | Stock Option (Right to Buy) | 953 | 393.30 | 374.8K | 953 | — | ↗ |
| 2024-05-17 | Keating Ashley M. | Director | A-Award | A | Stock Option (Right to Buy) | 953 | 393.30 | 374.8K | 953 | — | ↗ |
| 2024-05-17 | Gwadry-Sridhar Femida H. | Director | A-Award | A | Stock Option (Right to Buy) | 953 | 393.30 | 374.8K | 953 | — | ↗ |
| 2024-05-17 | DAVENPORT FRED B JR | Director | A-Award | A | Stock Option (Right to Buy) | 953 | 393.30 | 374.8K | 953 | — | ↗ |
| 2024-05-17 | Carley Brian T | Director | A-Award | A | Stock Option (Right to Buy) | 953 | 393.30 | 374.8K | 953 | — | ↗ |
| 2024-05-16 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,060 | 403.09 | 2.85M | 668,413 | — | ↗ |
| 2024-05-15 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 32,282 | 405.13 | 13.08M | 675,473 | — | ↗ |
| 2024-05-10 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,956 | 402.89 | 2.00M | 707,755 | — | ↗ |
| 2024-05-09 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,486 | 400.17 | 1.39M | 712,711 | — | ↗ |
| 2024-05-08 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 4,782 | 400.58 | 1.92M | 716,197 | — | ↗ |
| 2024-05-07 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 28,032 | 404.48 | 11.34M | 720,979 | — | ↗ |
| 2024-05-06 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 24,372 | 401.73 | 9.79M | 749,011 | — | ↗ |
| 2024-05-02 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 3,396 | 400.44 | 1.36M | 773,383 | — | ↗ |
| 2024-05-01 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 12,934 | 401.56 | 5.19M | 776,779 | — | ↗ |
| 2024-04-30 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 1,828 | 400.31 | 731.8K | 789,713 | — | ↗ |
| 2024-04-29 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 15,102 | 400.69 | 6.05M | 791,541 | — | ↗ |
| 2024-03-31 | McCarthy Cornelius P. III | Director | M-Exempt | D | Restricted Stock Unit | 63 | 0.00 | — | 186 | — | ↗ |
| 2024-03-31 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 72 | 0.00 | — | 448 | — | ↗ |
| 2024-03-31 | Carley Brian T | Director | M-Exempt | D | Restricted Stock Unit | 79 | 0.00 | — | 234 | — | ↗ |
| 2024-03-15 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 102 | 403.00 | 41.1K | 15,181 | — | ↗ |
| 2024-03-14 | Keating Ashley M. | Director | M-Exempt | D | Stock Option (Right to Buy) | 500 | 84.36 | 42.2K | 3,358 | — | ↗ |
| 2024-03-08 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,000 | 408.71 | 10.22M | 4,733,019 | — | ↗ |
| 2024-03-08 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 25,000 | 408.71 | 10.22M | 4,733,019 | — | ↗ |
| 2024-03-07 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 75,000 | 410.74 | 30.81M | 4,758,019 | — | ↗ |
| 2024-03-07 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 75,000 | 410.74 | 30.81M | 4,758,019 | — | ↗ |
| 2024-03-07 | Keating Ashley M. | Director | M-Exempt | D | Stock Option (Right to Buy) | 472 | 54.99 | 26.0K | 0 | — | ↗ |
| 2024-03-06 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 412.98 | 41.30M | 4,833,019 | — | ↗ |
| 2024-03-06 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 100,000 | 412.98 | 41.30M | 4,833,019 | — | ↗ |
| 2024-03-05 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 402.70 | 20.14M | 4,933,019 | — | ↗ |
| 2024-03-05 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 402.70 | 20.14M | 4,933,019 | — | ↗ |
| 2024-03-05 | GEIGER JESSE J | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 17,679 | 90.65 | 1.60M | 0 | — | ↗ |
| 2024-03-04 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 403.12 | 20.16M | 4,983,019 | — | ↗ |
| 2024-03-04 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 403.12 | 20.16M | 4,983,019 | — | ↗ |
| 2024-03-04 | GEIGER JESSE J | Officer | S-Sale | D | Common Stock | 22,321 | 403.03 | 9.00M | 3,824 | — | ↗ |
| 2024-03-01 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 80,000 | 401.88 | 32.15M | 5,033,019 | — | ↗ |
| 2024-03-01 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 80,000 | 401.88 | 32.15M | 5,033,019 | — | ↗ |
| 2024-03-01 | EWALD STEPHEN P | Officer | S-Sale | D | Common Stock | 350 | 400.79 | 140.3K | 13,341 | — | ↗ |
| 2024-02-29 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 20,000 | 393.71 | 7.87M | 5,113,019 | — | ↗ |
| 2024-02-29 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 20,000 | 393.71 | 7.87M | 5,113,019 | — | ↗ |
| 2024-02-29 | GEIGER JESSE J | Officer | S-Sale | D | Common Stock | 2,558 | 393.51 | 1.01M | 3,824 | — | ↗ |
| 2024-02-29 | EWALD STEPHEN P | Officer | S-Sale | D | Common Stock | 1,163 | 393.51 | 457.6K | 13,691 | — | ↗ |
| 2024-02-28 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 404.13 | 20.21M | 5,133,019 | — | ↗ |
| 2024-02-28 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 404.13 | 20.21M | 5,133,019 | — | ↗ |
| 2024-02-28 | Keating Ashley M. | Director | M-Exempt | A | Common Stock | 500 | 54.99 | 27.5K | 500 | — | ↗ |
| 2024-02-27 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 401.88 | 20.09M | 5,183,019 | — | ↗ |
| 2024-02-27 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 401.88 | 20.09M | 5,183,019 | — | ↗ |
| 2024-02-26 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 56,928 | 402.38 | 22.91M | 5,233,019 | — | ↗ |
| 2024-02-26 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 56,928 | 402.38 | 22.91M | 5,233,019 | — | ↗ |
| 2024-02-23 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 400.32 | 40.03M | 5,289,947 | — | ↗ |
| 2024-02-23 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 100,000 | 400.32 | 40.03M | 5,289,947 | — | ↗ |
| 2024-02-22 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 100,000 | 395.98 | 39.60M | 5,389,947 | — | ↗ |
| 2024-02-22 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 100,000 | 395.98 | 39.60M | 5,389,947 | — | ↗ |
| 2024-02-21 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 36,012 | 383.44 | 13.81M | 5,489,947 | — | ↗ |
| 2024-02-21 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 36,012 | 383.44 | 13.81M | 5,489,947 | — | ↗ |
| 2024-02-20 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 13,988 | 386.39 | 5.40M | 5,525,959 | — | ↗ |
| 2024-02-20 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 13,988 | 386.39 | 5.40M | 5,525,959 | — | ↗ |
| 2024-02-20 | Carley Brian T | Director | M-Exempt | A | Common Stock | 13,782 | 26.44 | 364.4K | 21,595 | — | ↗ |
| 2024-02-16 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 391.75 | 19.59M | 5,539,947 | — | ↗ |
| 2024-02-16 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 50,000 | 391.75 | 19.59M | 5,539,947 | — | ↗ |
| 2024-02-08 | McCarthy Cornelius P. III | Director | M-Exempt | A | Common Stock | 4,710 | 57.17 | 269.3K | 5,038 | — | ↗ |
| 2023-12-31 | McCarthy Cornelius P. III | Director | M-Exempt | D | Restricted Stock Unit | 82 | 0.00 | — | 0 | — | ↗ |
| 2023-12-31 | Kraft Robert O. | Director | M-Exempt | A | Common Stock | 94 | 0.00 | — | 376 | — | ↗ |
| 2023-12-31 | Carley Brian T | Director | M-Exempt | A | Common Stock | 103 | 0.00 | — | 7,813 | — | ↗ |
| 2023-12-15 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 2,009 | 303.00 | 608.7K | 15,283 | — | ↗ |
| 2023-12-14 | BURWIG SUSAN E | Officer | S-Sale | D | Common Stock | 10,391 | 304.15 | 3.16M | 17,292 | — | ↗ |
| 2023-12-01 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 24,039 | 273.26 | 6.57M | 5,589,947 | — | ↗ |
| 2023-12-01 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 24,039 | 273.26 | 6.57M | 5,589,947 | — | ↗ |
| 2023-11-30 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 7,871 | 272.18 | 2.14M | 5,613,986 | — | ↗ |
| 2023-11-30 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 7,871 | 272.18 | 2.14M | 5,613,986 | — | ↗ |
| 2023-11-30 | McCarthy Cornelius P. III | Director | A-Award | A | Restricted Stock Unit | 249 | 0.00 | — | 249 | — | ↗ |
| 2023-11-30 | Kraft Robert O. | Director | A-Award | A | Restricted Stock Unit | 286 | 0.00 | — | 286 | — | ↗ |
| 2023-11-30 | Carley Brian T | Director | A-Award | A | Restricted Stock Unit | 313 | 0.00 | — | 313 | — | ↗ |
| 2023-11-29 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 18,090 | 272.62 | 4.93M | 5,621,857 | — | ↗ |
| 2023-11-29 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 3,167 | 272.87 | 864.2K | 5,639,947 | — | ↗ |
| 2023-11-28 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 21,833 | 273.66 | 5.97M | 5,643,114 | — | ↗ |
| 2023-11-28 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 21,833 | 273.66 | 5.97M | 5,643,114 | — | ↗ |
| 2023-11-27 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,000 | 276.10 | 6.90M | 5,664,947 | — | ↗ |
| 2023-11-27 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 25,000 | 276.10 | 6.90M | 5,664,947 | — | ↗ |
| 2023-11-22 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,000 | 277.81 | 6.95M | 5,689,947 | — | ↗ |
| 2023-11-22 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 25,000 | 277.81 | 6.95M | 5,689,947 | — | ↗ |
| 2023-11-21 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 25,000 | 277.37 | 6.93M | 5,714,947 | — | ↗ |
| 2023-11-21 | Medpace Investors, LLC | 10% Owner | S-Sale | D | Common Stock | 25,000 | 277.37 | 6.93M | 5,714,947 | — | ↗ |
| 2023-11-20 | Troendle August J. | Director / Officer / 10% Owner | S-Sale | D | Common Stock | 50,000 | 275.45 | 13.77M | 5,739,947 | — | ↗ |
Executive team
Top executives
EBIT / Employee
91.9K
Shares Outstanding
28.56M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 937.4K | 492.4K | — | 10.00M | — | 14.0K | 11.44M | 87.38% | ↗ |
| 2 | 2025 | Stephen P. Ewald, General Counsel and Corporate Secretary | 710.4K | 497.4K | — | 1.50M | — | 15.9K | 2.72M | 55.07% | ↗ |
| 3 | 2025 | Susan E. Burwig, Executive Vice President, Operations | 641.7K | 240.7K | — | 1.50M | — | 14.0K | 2.40M | 62.59% | ↗ |
| 4 | 2025 | Jesse J. Geiger, President | 459.7K | 172.5K | — | 1.00M | — | 14.0K | 1.65M | 60.75% | ↗ |
| 5 | 2024 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 866.3K | 649.8K | — | 7.07M | — | 14.1K | 8.60M | 82.21% | ↗ |
| 6 | 2024 | Stephen P. Ewald, General Counsel and Corporate Secretary | 671.7K | 352.7K | 3.77M | — | — | 39.7K | 4.83M | 77.99% | ↗ |
| 7 | 2024 | Susan E. Burwig, Executive Vice President, Operations | 606.7K | 318.6K | 3.77M | — | — | 13.8K | 4.71M | 80.06% | ↗ |
| 8 | 2024 | Jesse J. Geiger, President | 421.6K | 221.4K | 2.83M | — | — | 13.8K | 3.48M | 81.15% | ↗ |
| 9 | 2023 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 814.3K | 814.4K | — | — | — | 17.3K | 1.65M | 0.00% | ↗ |
| 10 | 2023 | Stephen P. Ewald, General Counsel and Corporate Secretary | 598.1K | 418.9K | — | — | — | 107.3K | 1.12M | 0.00% | ↗ |
| 11 | 2023 | Susan E. Burwig, Executive Vice President, Operations | 549.3K | 384.6K | — | — | — | 11.3K | 945.1K | 0.00% | ↗ |
| 12 | 2023 | Jesse J. Geiger, President | 399.5K | 279.7K | — | — | — | 11.3K | 690.5K | 0.00% | ↗ |
| 13 | 2022 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 770.3K | 772.5K | 206.5K | — | — | 135.8K | 1.89M | 10.95% | ↗ |
| 14 | 2022 | Stephen P. Ewald, General Counsel and Corporate Secretary | 524.3K | 367.0K | 206.5K | — | — | 112.9K | 1.21M | 17.05% | ↗ |
| 15 | 2022 | Susan E. Burwig, Executive Vice President, Operations | 509.2K | 357.5K | 206.5K | — | — | 10.3K | 1.08M | 19.06% | ↗ |
| 16 | 2022 | Jesse J. Geiger, President | 368.3K | 258.0K | 206.5K | — | — | 10.3K | 843.0K | 24.49% | ↗ |
| 17 | 2021 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 696.7K | 711.0K | — | 4.41M | — | 129.8K | 5.95M | 74.15% | ↗ |
| 18 | 2021 | Stephen P. Ewald, General Counsel and Corporate Secretary | 482.5K | 338.8K | — | 1.61M | — | 89.0K | 2.52M | 63.91% | ↗ |
| 19 | 2021 | Susan E. Burwig, Executive Vice President, Operations | 466.7K | 329.0K | — | 1.50M | — | 9.8K | 2.31M | 65.07% | ↗ |
| 20 | 2021 | Jesse J. Geiger, President | 299.4K | 238.0K | — | 653.3K | — | 9.8K | 1.20M | 54.42% | ↗ |
| 21 | 2020 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 607.5K | 500.0K | — | 3.00M | — | 24.6K | 4.14M | 72.63% | ↗ |
| 22 | 2020 | Stephen P. Ewald, General Counsel and Corporate Secretary | 466.0K | 237.5K | — | 1.20M | — | 46.7K | 1.95M | 61.57% | ↗ |
| 23 | 2020 | Susan E. Burwig, Executive Vice President, Operations | 443.4K | 225.0K | — | 1.20M | — | 9.8K | 1.88M | 63.93% | ↗ |
| 24 | 2020 | August J. Troendle, President and Chief Executive Officer Jesse J. Geiger, Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 607.5K | 500.0K | — | — | — | 24.6K | 1.13M | 0.00% | ↗ |
| 25 | 2019 | August J. Troendle, Chief Executive Officer Kevin M. Brady, Chief Financial Officer and Treasurer | 503.6K | — | 1.16M | 5.96M | — | 89.0K | 7.71M | 92.32% | ↗ |
| 26 | 2019 | August J. Troendle, President and Chief Executive Officer Jesse J. Geiger, Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 503.6K | — | 1.16M | 5.96M | — | 89.0K | 7.71M | 92.32% | ↗ |
| 27 | 2019 | August J. Troendle President and Chief Executive Officer | 503.6K | — | 1.16M | 5.96M | — | 89.0K | 7.71M | 92.32% | ↗ |
| 28 | 2019 | Stephen P. Ewald, General Counsel and Corporate Secretary | 419.1K | 150.0K | 700.0K | 1.10M | — | 64.1K | 2.43M | 73.94% | ↗ |
| 29 | 2019 | Susan E. Burwig Executive Vice President, Operations | 419.1K | 150.0K | 700.0K | 1.10M | — | 64.1K | 2.43M | 73.94% | ↗ |
| 30 | 2019 | Jesse J. Geiger Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 409.5K | — | 574.0K | 890.9K | — | 9.5K | 1.88M | 77.76% | ↗ |
| 31 | 2019 | Susan E. Burwig, Executive Vice President, Operations | 409.5K | — | 574.0K | 890.9K | — | 9.5K | 1.88M | 77.76% | ↗ |
| 32 | 2019 | Stephen P. Ewald General Counsel and Corporate Secretary | 299.8K | 110.0K | 300.0K | 537.7K | — | 6.0K | 1.25M | 66.83% | ↗ |
| 33 | 2018 | Stephen P. Ewald, General Counsel and Corporate Secretary | 407.1K | 142.5K | — | 147.0K | — | 33.1K | 729.8K | 20.15% | ↗ |
| 34 | 2018 | Susan E. Burwig Executive Vice President, Operations | 407.1K | 142.5K | — | 147.0K | — | 33.1K | 729.8K | 20.15% | ↗ |
| 35 | 2018 | Jesse J. Geiger Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 400.3K | 120.0K | — | 147.0K | — | 9.3K | 676.5K | 21.73% | ↗ |
| 36 | 2018 | Susan E. Burwig, Executive Vice President, Operations | 400.3K | 120.0K | — | 147.0K | — | 9.3K | 676.5K | 21.73% | ↗ |
| 37 | 2018 | August J. Troendle President and Chief Executive Officer | 420.3K | — | — | — | — | 108.0K | 528.3K | 0.00% | ↗ |
| 38 | 2018 | August J. Troendle, President and Chief Executive Officer Jesse J. Geiger, Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 420.3K | — | — | — | — | 108.0K | 528.3K | 0.00% | ↗ |
| 39 | 2017 | Susan E. Burwig Executive Vice President, Operations | 394.6K | 79.2K | — | 171.0K | — | 48.7K | 693.5K | 24.66% | ↗ |
| 40 | 2017 | Jesse J. Geiger Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 378.0K | 100.0K | — | 171.0K | — | 9.0K | 658.0K | 25.99% | ↗ |
| 41 | 2017 | August J. Troendle President and Chief Executive Officer | 418.5K | — | — | — | — | 179.5K | 598.1K | 0.00% | ↗ |
| 42 | 2016 | August J. Troendle President and Chief Executive Officer | 410.0K | — | — | 358.0K | — | 69.0K | 837.0K | 42.77% | ↗ |
| 43 | 2016 | Jesse J. Geiger Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 341.7K | 200.0K | — | 132.5K | — | 9.0K | 683.2K | 19.40% | ↗ |
| 44 | 2016 | Susan E. Burwig Executive Vice President, Operations | 377.9K | 132.6K | — | 53.0K | — | 103.6K | 667.1K | 7.94% | ↗ |
| 45 | 2015 | August J. Troendle President and Chief Executive Officer | 270.4K | — | 7.43M | — | — | 113.5K | 7.82M | 95.09% | ↗ |
| 46 | 2015 | Susan E. Burwig Executive Vice President, Operations | 350.4K | 62.9K | — | — | — | 20.6K | 433.9K | 0.00% | ↗ |
| 47 | 2015 | Jesse J. Geiger Chief Financial Officer and Chief Operating Officer, Laboratory Operations | 300.0K | 71.8K | — | — | — | 9.0K | 380.8K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| August James Troendle | Chairman & Chief Executive Officer | 1M | — |
| Susan E. Burwig | Executive Vice President of Operations | 1M | female |
| Stephen Ewald | Chief Compliance Officer, General Counsel & Corporate Secretary | 1M | male |
| Jesse J. Geiger | President | 896.4K | male |
| Kevin Brady | Chief Financial Officer & Treasurer | 646.1K | male |
| Weimin Gai | Senior Vice President of Biometrics | — | male |
| Brandon Ebken | Chief Information Officer | — | male |
| John T. Wynne | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | — | male |
| Lauren Morris | Associate Director of Investors Relations | — | female |
| Todd Meyers | Vice President of Business Development & Marketing | — | male |
ESG Rating
ESG Score History MEDICAL - DIAGNOSTICS & RESEARCH
Benchmark vs Sector
Political Trading Activity (25M)
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | 2026-05-29 | David Taylor | OH02 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2026-02-26 | 2026-03-09 | David Taylor | OH02 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2026-01-29 | 2026-02-03 | David Taylor | OH02 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2026-01-16 | 2026-02-03 | David Taylor | OH02 | — | Sale | $1,001 - $15,000 | ↗ |
| 2026-01-15 | 2026-02-13 | Gilbert Cisneros | CA31 | — | Sale (Full) | $15,001 - $50,000 | ↗ |
| 2025-10-09 | 2025-11-18 | Gilbert Cisneros | CA31 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2025-08-04 | 2025-09-15 | Lisa McClain | MI09 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2025-07-24 | 2025-08-15 | Gilbert Cisneros | CA31 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-07-23 | 2025-09-03 | David Taylor | OH02 | — | Sale | $1,001 - $15,000 | ↗ |
| 2025-07-22 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2024-07-26 | 2024-08-15 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2024-06-21 | 2024-07-09 | Josh Gottheimer | NJ05 | Joint | Sale | $1,001 - $15,000 | ↗ |
| 2024-01-24 | 2024-02-15 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2023-11-13 | 2023-12-11 | Michael Patrick Guest | MS03 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2022-07-22 | 2022-08-29 | Josh Gottheimer | NJ05 | — | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2021-10-26 | 2021-11-15 | Josh Gottheimer | NJ05 | Joint | Sale (Partial) | $1,001 - $15,000 | ↗ |
| 2020-12-10 | 2021-01-11 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-12-08 | 2021-01-07 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
| 2020-11-03 | 2020-11-05 | Gilbert Cisneros | CA31 | — | Purchase | $1,001 - $15,000 | ↗ |
| 2020-10-29 | 2020-11-05 | Josh Gottheimer | NJ05 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MEDP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
